An updated analysis of hepatitis C virus genotypes and subtypes based on the complete coding region.
about
Hepatitis C virus protease inhibitor-resistance mutations: our experience and reviewMedicinal plants against hepatitis C virusHCV genotypes, characterization of mutations conferring drug resistance to protease inhibitors, and risk factors among blood donors in São Paulo, BrazilExpanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resourceComputational models of liver fibrosis progression for hepatitis C virus chronic infection.The linker region of NS3 plays a critical role in the replication and infectivity of hepatitis C virus.Recombinant hepatitis C virus envelope glycoprotein vaccine elicits antibodies targeting multiple epitopes on the envelope glycoproteins associated with broad cross-neutralization.Efficient virus assembly, but not infectivity, determines the magnitude of hepatitis C virus-induced interferon alpha responses of plasmacytoid dendritic cells.Determining major genotypes of hepatitis C virus among transplant recipients by real-time polymerase chain reaction assayHepatitis C virus genotype 7, a new genotype originating from central Africa.Intra-host diversity and evolution of hepatitis C virus endemic to Côte d'IvoireEpidemic history of hepatitis C virus infection in two remote communities in Nigeria, West Africa.Demographic characteristics and intravenous drug use among hepatitis C patients in the Kota Setar district, Kedah, Malaysia.A re-evaluation of the origin of hepatitis C virus genotype 2 in West Africa.Pan-genotypic Hepatitis C Virus Inhibition by Natural Products Derived from the Wild Egyptian ArtichokeMolecular characterization of HCV in a Swedish county over 8 years (2002-2009) reveals distinct transmission patterns.The anti-genomic (negative) strand of Hepatitis C Virus is not targetable by shRNA.A novel hepacivirus with an unusually long and intrinsically disordered NS5A protein in a wild Old World primate.Immunogenicity and functional characterization of Leishmania-derived hepatitis C virus envelope glycoprotein complex.Naturally occurring resistance mutations to inhibitors of HCV NS5A region and NS5B polymerase in DAA treatment-naïve patients.Transmission of hepatitis C virus among intravenous drug users in the Uppsala region of Sweden.Hepatitis C virus RNA replication and virus particle assembly require specific dimerization of the NS4A protein transmembrane domain.Discrepancy between Hepatitis C Virus Genotypes and NS4-Based Serotypes: Association with Their Subgenomic Sequences.The role of chemokines in acute and chronic hepatitis C infection.The role of chemokines in hepatitis C virus-mediated liver diseaseClosing the Gap: The Challenges of Treating Hepatitis C Virus Genotype 3 Infection.A study of the allosteric inhibition of HCV RNA-dependent RNA polymerase and implementing virtual screening for the selection of promising dual-site inhibitors with low resistance potential.Hepatitis C Virus Infection in Chronic Kidney Disease.Hepatitis C virus genetic variability and the presence of NS5B resistance-associated mutations as natural polymorphisms in selected genotypes could affect the response to NS5B inhibitors.Estimating the Size of the HCV Infection Prevalence: A Modeling Approach Using the Incidence of Cases Reported to an Official Notification System.Polymorphisms at IL28B gene as predictors of viral relapse in genotype 4 Egyptian hepatitis C patients.Prevalence of polymorphisms with significant resistance to NS5A inhibitors in treatment-naive patients with hepatitis C virus genotypes 1a and 3a in Sweden.Isolate-dependent use of claudins for cell entry by hepatitis C virus.A new subtype of hepatitis C virus genotype 3: analysis of available evidenceMass balance and metabolite profiling of steady-state faldaprevir, a hepatitis C virus NS3/4 protease inhibitor, in healthy male subjects.Chemical genetics-based development of small molecules targeting hepatitis C virus.Chronic hepatitis C virus infection in India: Regional demographics and distribution of viral genotypes.Cost-utility analysis of sofosbuvir for the treatment of genotype 2 chronic hepatitis C in Japan.Biophysical Studies on HCV 1a NS3/4A Protease and Its Catalytic Triad in Wild Type and Mutants by the In Silico Approach.The wild Egyptian artichoke as a promising functional food for the treatment of hepatitis C virus as revealed via UPLC-MS and clinical trials.
P2860
Q24628717-8D2450D0-F786-4C49-BC32-74E5F871EF13Q27005739-14E689A8-A2A7-4778-A706-0807CFEDDA78Q28538943-92107436-B51F-4623-8CEB-CFB22DE2AABFQ33777199-F4328640-1EE1-4AAF-9A00-273DD1F78695Q33995110-006010F5-E675-4A43-A491-9DD72E0148CDQ34262069-C232C9A5-EE56-42D3-93FC-41BA0CCFB6DFQ34594986-AF4C9615-4A71-44D1-ABED-8B5D8FC7EFFAQ35110983-B71DBF9D-DBB7-48A6-894A-9BC140BE2F66Q35157630-5CA8498A-7F4D-4A47-94ED-DE6F75362C37Q35331109-E6A49BCC-0CF4-4604-B00E-0EDDAF311B02Q36112861-5F5C5A21-DBE0-4248-B875-B4E5175F03E0Q36112907-D0EC04D8-F02B-4CE5-8744-B6137B2E63C2Q36192394-FD385A38-F759-426A-817D-FEEEFE01E659Q36376619-40330E72-BEBA-4839-941B-8B7712732B02Q36524016-4F81D7BF-15CE-4167-95D7-251D46B6E3E1Q36554870-F019FDD3-1D94-42F7-AA73-406E06C600D0Q36740829-1CB4631C-C722-4BFC-BF1B-C0A9F09E1EF7Q37123401-643BEA8F-4BF2-4AAD-9BD2-8D4BA46D2214Q37144953-1DC01384-EB56-4BFB-B78E-797B933B00B7Q37426527-4807E42A-9C82-480D-9672-46585B3E2D32Q37491694-1972638B-CF31-4F5D-92F1-F1C37626E349Q37547774-E5A794F5-AA03-4E5E-B530-55588CC5BB18Q37631645-3B615476-CBA5-4861-AE98-900B191D97F9Q38129709-1D3CA50E-D6BA-434A-B4AC-815D2823F8A1Q38197441-3F0001C1-4449-416F-A29A-AB56395CAA5FQ38735317-2488CFF6-719B-4B23-86CB-A9A504D1FF79Q38796994-E85D89BE-8900-4CC2-8FE8-90D92976C670Q38812607-7AFBB4F6-4AAB-414A-BE16-161114FBC37CQ38849307-ADF69F9D-CEBF-4A65-9410-1A37B5A593D8Q38871895-BED047D8-2813-4193-9BAA-BAD4340D7523Q38995225-2D546654-DD85-4638-BCAF-3686E90D61B4Q39020651-2E48CB0E-3F05-4D65-BE3B-4B028804C8F1Q39138231-6774575D-70CE-4895-BAE8-3B02B921DE69Q39338665-AD9DEFB0-315B-427A-91D0-A2FCAD646838Q39682787-1CD003BE-765B-4E8A-9532-058E7281B674Q40063790-8D361CDC-907C-4E77-932B-5B284D76F149Q40451958-D6FA3FE3-C96B-4071-8CC1-74C20C328ED1Q40547120-5EE21E78-0630-4495-8B8A-1D99E69139CAQ40696891-960BEF04-2AC3-4818-9405-38BF3C2AB283Q40703891-7136E6F5-A1CD-45AE-962E-DB50B5F44325
P2860
An updated analysis of hepatitis C virus genotypes and subtypes based on the complete coding region.
description
2011 nî lūn-bûn
@nan
2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
An updated analysis of hepatit ...... on the complete coding region.
@ast
An updated analysis of hepatit ...... on the complete coding region.
@en
An updated analysis of hepatit ...... on the complete coding region.
@nl
type
label
An updated analysis of hepatit ...... on the complete coding region.
@ast
An updated analysis of hepatit ...... on the complete coding region.
@en
An updated analysis of hepatit ...... on the complete coding region.
@nl
prefLabel
An updated analysis of hepatit ...... on the complete coding region.
@ast
An updated analysis of hepatit ...... on the complete coding region.
@en
An updated analysis of hepatit ...... on the complete coding region.
@nl
P2093
P2860
P1433
P1476
An updated analysis of hepatit ...... on the complete coding region.
@en
P2093
Gillian M G Lau
Grace M L Lau
Masashi Mizokami
Masaya Sugiyama
Tatsunori Nakano
P2860
P304
P356
10.1111/J.1478-3231.2011.02684.X
P577
2011-12-05T00:00:00Z